© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
December 2018
Guidelines Updates in Diabetes and Cardiovascular Disease
December 30, 2018
Article
Evidence-Based Diabetes Management
A statement on hypoglycemia, an consensus document from cardiologists on diabetes and CVD, and guidelines on treating cholesterol.
A Paradigm Shift Highlights the Need to Reduce CV Risk in Diabetes
December 27, 2018
Article
Evidence-Based Diabetes Management
From the Editor in Chief of Evidence-Based Diabetes Management.™ Dr Gabbay is senior vice presdient and chief medical officer of Joslin Diabetes Center in Boston, Massachusetts.
Contributor: Increasing Awareness About Peripheral Artery Disease Can Save Limbs and Lives
December 27, 2018
Article
Evidence-Based Diabetes Management
A commentary from a cardiologist who practices in the Mississippi Delta, where a comparatively high share of the population is at risk for diabetes and peripheral artery disease.
For Payers, Cost Is the Downside of Continuing Cardiovascular Outcomes Trials in Current Form
December 27, 2018
Article
Evidence-Based Diabetes Management
A perspective on the current FDA guidance for diabetes therapies.
After FDA Panel Vote, Some See Next Generation of Cardiovascular Safety Trials for Diabetes Drugs
December 27, 2018
Article
Evidence-Based Diabetes Management
Concerns over cost should lead FDA to recommend adjustments to these trials, which many say have led to unexpected knowledge and changed the field of diabetes care.
Time for a "New Goalpost" in Cardiovascular Outcomes Trials, Kosiborod Suggests
December 26, 2018
Article
Evidence-Based Diabetes Management
Leading cardiologist Mikhail N. Kosiborod, MD, FACC, FAHA, discusses how the FDA's 2008 guidance requiring cardiovascular outcomes trials has changed the treatment landscape in diabetes care and what expectations might look like going forward.
Clinical Evidence for and Cost-Effectiveness of Advanced Cellular Tissue Products for the Treatment of Diabetic Foot Ulcers
December 22, 2018
Article
Evidence-Based Diabetes Management
An estimated 30 million Americans are living with diabetes. Additionally, 84 million have prediabetes, a condition that will result in type 2 diabetes within 5 years if not properly treated. Long regarded as one of the most prevalent chronic diseases in United States, diabetes is also a leading cause of disability and the seventh-leading cause of death. Less discussed is one of the most common complications of diabetes: diabetic foot ulcers. If not properly treated with standard and adjunctive care, these chronic wounds can lead to permanent disability and premature death.